Suggest Mobile Phase for Sertraline HCl Impurity Method for, with good separation between "USP Sertaline HCl Racemic Mixture and Sertraline HCl".

Required naproxen sodium Assay Alternate method in UV Spectro.
Diluent=?
UV spectro parameters=?

During batch file run after five std. Run pressure drop occurs due to which shift in RT. How can we file an incident report. What reason and explanation and remedies we file

In analytical method development, particularly for analyzing active pharmaceutical ingredients (APIs) and their impurities, the pKa value of a compound is a fundamental parameter.

Why is pKa so vital?

The pKa value is the specific pH at which a molecule exists in a state of equal equilibrium between its ionized and unionized forms (50% ionized, 50% unionized). This balance is crucial because the ionization state directly dictates how a compound interacts with the HPLC system, influencing its retention time, selectivity, and overall peak shape.


Key Applications of pKa in Optimizing HPLC Methods

Strategic Mobile Phase pH Selection:

Choosing a mobile phase pH relative to the analyte's pKa is essential for controlling its ionization state and, consequently, its retention and resolution.

General Guideline: For stable ionization and reproducible chromatography, it is recommended to work at a pH that is at least 2 units away from the pKa value (pKa ± 2).

Achieving Superior Peak Shape:

The unionized form of a compound is typically more hydrophobic, allowing for stronger interactions with the stationary phase. This results in sharper, more symmetrical peaks.

Conversely, the ionized form is more hydrophilic and often shows poor retention, leading to undesirable broad, weak, or tailing peaks.

Improving Selectivity Between Analytes:

Compounds with different pKa values can be effectively separated by fine-tuning the mobile phase pH.

Even small adjustments in pH can significantly enhance resolution and selectivity, facilitating the separation of closely eluting peaks.

Ensuring Method Robustness:

A method operating at a mobile phase pH close to an analyte's pKa is highly sensitive to minor pH fluctuations. This can lead to inconsistent retention times and affect system suitability.

Working at a pH away from the pKa makes the method more robust and less susceptible to these small variations.

✔ In Summary: The pKa is more than just a number; it is a powerful guiding tool. By making pKa-driven decisions, analytical scientists can optimize retention, improve selectivity, prevent peak tailing, and ensure the robustness of their HPLC methods, ultimately leading to faster development and more reliable results.

Want to remove this hump / behavior.
System is time gradient. Diluent is acetonitrile.
Suggestions please..??

Please inform me of UV calibration with total perameter and it's procese

Suggest Mobile:
Composition isocrated / Gradient for
Oteseconazole:SHR8008X:SHR8008JA retention time with good separation.

Choosing the right buffers and solvents is critical in LC-MS because the entire mobile phase directly enters the mass spectrometer. Compatibility with the ionization source (like ESI or APCI) is essential for high-quality data.

1. Why Volatile Buffers are Essential
Non-volatile salts, such as phosphate buffers, are unsuitable for LC-MS. As the mobile phase evaporates, these salts leave a residue that can:

Contaminate and clog the ion source.

Cause signal suppression.

Increase background noise.

Necessitate frequent and costly maintenance.

Volatile buffers are the solution. They provide stable pH control while being easily removed in the gas phase.

Benefits of Volatile Buffers:

High Sensitivity: They evaporate cleanly, allowing analytes to ionize efficiently without interference.

Low Background: Complete evaporation minimizes background ions, leading to a cleaner spectrum and better signal-to-noise.

System Stability: They prevent the residue buildup that plagues systems using non-volatile salts.

Common Volatile Buffers:

Ammonium Acetate (pH range ~4-6)

Ammonium Formate (pH range ~3-6)

Formic Acid / Acetic Acid (for acidic conditions)

Ammonium Hydroxide (for basic conditions)

2. Why Non-Polar Solvents Should Be Avoided
The choice of organic modifier is equally important. Non-polar solvents (like hexane or toluene) are not recommended for typical reversed-phase LC-MS for several reasons:

Poor Miscibility: Most LC-MS mobile phases are aqueous. Non-polar solvents are immiscible with water, which can cause phase separation.

Low Volatility & Unstable Spray: They do not evaporate efficiently in the MS source, leading to an unstable spray, a noisy baseline, and system contamination.

Ion Suppression: Their low dielectric constant is not conducive to good ion formation in ESI, resulting in poor signal intensity.

Safety Concerns: They often have higher toxicity and flammability.

3. Preferred Solvents for LC-MS
The most commonly used solvents are polar and volatile, such as Methanol and Acetonitrile.

These are ideal because they are:

Fully miscible with water.

Highly volatile, ensuring easy removal in the ion source.

Able to produce stable electrospray droplets, which promotes efficient ionization.

#PharmaceuticalAnalysis #MethodDevelopment #Principle #LCMS #UHPLC #HPLC #GC #GCMS #Volatile_Buffers #Non_polar_solvents #USP #IP #WHO #CDCSO #ICH #MHRA #AnalyticalChemistry #Solactivity #DrugDevelopment #Chemist #validation #science #pharma #GLP #SCIENCE #analytical #scientist #knowledge #sharing

Hello everyone im conducting HAA9 analysis in water samples with SPE in LC MS/MS and im observing reduced areas of the peaks over the months. The LC works normally for other methods. Can someone has the same problem in HAA analysis? Or doing the same analysis? The LCMS is the Shimadzu 8050. Thank you!

In UPLC during RP-HPLC Run with mobile phase as 0.1% TFA+ Water and 0.1%TFA+ ACN with 55 C column temp., the peak keeps shifting to wards left as the sequence continues.

What could be the reason.
Initially the for few runs the RT was consistent.

Any suggestions to look in to ?

Hello
I need full course on Hplc
I know the princble
I need help in how work & troubleshooting

Please Provide me the Tropicamide 1% Eye Drop HPLC related substance Method of analysis and impurities limit.

Best mobile phase for assay and their ratio mobile phase for better' resolution

How make integration on empower for hplc

Excited to announce a powerful new feature in HPLC Calculator app ?

? Fine-tuned on real HPLC problems and solutions
? Aligned with international analytical guidelines
? Helps identify issues, suggest fixes, and optimize methods

Whether you’re facing peak shape issues, retention problems, or compliance challenges, the AI Assistant is designed to provide practical, guideline-based answers.

Available now inside the app — making HPLC analysis smarter and easier than ever!
#HPLC_Calculator

Download it now

Appstore
https://apps.apple.com/eg/app/hplc-calculator/id1600330994


Play store

https://play.google.com/store/apps/details?id=com.Youhana.HPLC_Calculator

Now I try to analysis syrup contain Vit.D3 and calcium by hplc but i have difficulty separating to get clear result as assay
Can you give any method or tips

When developing an HPLC method, we often focus on column chemistry, mobile phase composition, and detection. But what happens when the compound itself is chiral?
Enantiomers — mirror-image molecules — behave identically in most achiral environments, which means they often co-elute as a single peak on standard C18 or C8 columns. In biological systems, however, their behavior can be dramatically different:
One enantiomer may provide the therapeutic effect.
The other may be inactive, or even harmful.
This is why regulatory agencies (ICH, FDA, EMA) require chiral separation and quantification during method development and validation. Enantiomeric purity is not only a regulatory requirement but also essential for patient safety and drug efficacy.
Strategies for Chiral Separation in HPLC:
Chiral Stationary Phases (CSPs) – polysaccharide, cyclodextrin, protein, or Pirkle-type columns that enable selective interactions.
Chiral Mobile Phase Additives (CMPAs) – such as cyclodextrins forming transient diastereomeric complexes.
Indirect Approach (Derivatization) – converting enantiomers into diastereomers with chiral reagents (e.g., Marfey’s, Mosher’s) for separation on achiral columns.
Key Considerations in Method Development:
Screening multiple CSPs to identify the best selectivity.
Selecting the appropriate elution mode (normal-phase, reversed-phase, polar organic).
Optimizing pH and temperature to improve resolution.
Ensuring scalability for both analytical and preparative applications.
In modern pharmaceutical analysis, chirality is more than just a separation challenge — it is a critical quality attribute that guarantees both drug safety and efficacy.
For professionals in analytical R&D and QC, developing strong expertise in chiral HPLC method development is essential. Chirality is not just chemistry; it is directly linked to patient safety.
#HPLC #Chirality #MethodDevelopment #AnalyticalChemistry #Pharma #DrugSafety #QualityControl

Impurities are unwanted chemicals that may be present in drug substances or finished products as a result of manufacturing, storage, or handling.

Types of Impurities
Process-related → unreacted starting materials, by-products, catalysts.
Degradation-related → formed through heat, oxidation, hydrolysis, or light.
Residual solvents → examples include methanol and dichloromethane.
Enantiomeric impurities → incorrect stereoisomers in chiral drugs.
According to ICH Q3A/Q3B, any impurity at or above 0.1% must be identified, with stricter thresholds for genotoxic impurities.

Identifying Impurities Using HPLC
Detection
The main API peak appears alongside smaller impurity peaks.
Characterization
Compare retention times with reference standards.
Use PDA detectors to check peak purity.
Confirm identity by co-injection with standards.
Structural Identification
LC-MS provides molecular weight and fragmentation patterns.
LC-NMR or LC-FTIR supplies structural fingerprints.
Together, these techniques give the complete chemical identity.

Examples of Well-Known Impurities

Nitrosamines (e.g., NDMA, NDEA)
Discovered in valsartan, ranitidine, and metformin between 2018–2019.
Classified as probable human carcinogens.
Regulatory limits are extremely low (nanogram levels).
Identified using HPLC-MS/MS.
p-Aminophenol (Paracetamol)
A toxic degradation product affecting liver and kidney.
Strictly limited to ≤0.1%.
Formaldehyde / Acetaldehyde
Residual solvent-related impurities found in excipients.
Detected using derivatization followed by HPLC.
Epimer impurities in chiral drugs
Wrong stereoisomers can be inactive or harmful.
The thalidomide case highlighted the risks.
Controlled and identified using chiral HPLC columns.

Why Impurity Profiling is Essential
Patient safety → prevents toxic exposure.
Regulatory compliance → required by ICH and FDA.
Process understanding → reveals weaknesses in synthesis or storage.
Shelf-life assurance → guarantees product safety until expiry.

Key Takeaway

Finding an extra peak in an HPLC chromatogram is only the first step. Comprehensive quality control requires:

Detection – observing the impurity peak.
Identification – determining chemical structure with advanced techniques.
Control – ensuring levels remain below regulatory limits.